Monitoring Therapy of Low-Grade Lymphoma by Pcr

Cabanillas, Fernando F.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project (R01)
• Project #: 5R01CA062518-04
• Application #: 2103826
• Study Section: Special Emphasis Panel (SRC (57))
• Project Start: 1993-09-01
• Project End: 1998-06-30
• Budget Start: 1996-07-01
• Budget End: 1998-06-30
• Support Year: 4
• Fiscal Year: 1996

Institution

• Name: University of Texas MD Anderson Cancer Center
• Department: Other Basic Sciences
• Type: Other Domestic Higher Education
• DUNS #: 001910777
• City: Houston
• State: TX
• Country: United States
• Zip Code: 77030

Publications

Ha, Chul S; Cabanillas, Fernando; Lee, Ming S et al. (2005) A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphoma. Int J Radiat Oncol Biol Phys 63:188-93

Lopez-Guillermo, A; Cabanillas, F; McLaughlin, P et al. (2000) Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: update of the MDACC series. Ann Oncol 11 Suppl 1:137-40

Lopez-Guillermo, A; Cabanillas, F; McDonnell, T I et al. (1999) Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma. Blood 93:3081-7

Lopez-Guillermo, A; Cabanillas, F; McLaughlin, P et al. (1998) The clinical significance of molecular response in indolent follicular lymphomas. Blood 91:2955-60

Ha, C S; Cabanillas, F; Lee, M S et al. (1997) Serial determination of the bcl-2 gene in the bone marrow and peripheral blood after central lymphatic irradiation for stages I-III follicular lymphoma: a preliminary report. Clin Cancer Res 3:215-9